CD9 and CD63 are 2 well‐known exosomal surface markers; interestingly, T cell–derived CD9+ and CD63+ exosomes had the highest fold induction in SLE patients compared to controls. This evidence concerns the gene CD63 and systemic lupus erythematosus.